In the BioHarmony Drug Report Database

"Preview" Icon

Paliperidone

Invega, Paliperidone Janssen, Paliperidone Janssen-Cilag International, Trevicta, Xeplion (paliperidone) is a small molecule pharmaceutical. Paliperidone was first approved as Invega on 2006-12-19. It is used to treat bipolar disorder, depressive disorder, schizophrenia, and schizophrenia spectrum and other psychotic disorders in the USA. It has been approved in Europe to treat psychotic disorders and schizophrenia.

 

Trade Name

 

Invega, Paliperidone Janssen, Paliperidone Janssen-Cilag International, Trevicta, Xeplion
 

Common Name

 

paliperidone
 

ChEMBL ID

 

CHEMBL1621
 

Indication

 

bipolar disorder, depressive disorder, psychotic disorders, schizophrenia, schizophrenia spectrum and other psychotic disorders
 

Drug Class

 

Antipsychotics (risperidone type)

Image (chem structure or protein)

Paliperidone structure rendering